Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
Remdesivi (IV injection) in NHP results in GS 441524 being present in serum at concentrations 1000-fold higher than Remdesivir throughout a 7-day treatment course
InChiKey: NQWRSILGEXNJIT-UHFFFAOYSA-N
InChiKey: ZJIHMALTJRDNQI-OLALXQGDSA-N
Currently it is in phase I trials for patients with advanced haematological tumours
Solubility: DMSO : 27 mg/mL (61
Terlipressin Catalog No.:M24127-C Remdesivi (IV injection) in NHPTerlipressin is a vasopressin analogue with potent vasoactive properties. Terlipressin is a highly selective vasopressin V1 receptor agonist that reduces the splanchnic blood flow and portal pressure and controls acute variceal bleeding. Terlipressin exerts anti inflammatory and anti oxidative effects. Terlipressin has the potential for hepatorenal syndrome and norepinephrine resistant septic shock research. Product information CAS Number: 14636 12 5
US$ 26.95
US$ 38.95
US$ 63.63
US$ 18.95
US$ 13.95
US$ 22.00
US$ 14.50
US$ 832.16
US$ 157.36
US$ 17.00
US$ 13.95